Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos

Detalhes bibliográficos
Autor(a) principal: Barros, Daniele Costa Souza
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da Universidade Federal de Alagoas (UFAL)
Texto Completo: http://www.repositorio.ufal.br/handle/riufal/5880
Resumo: Leishmaniasis, according to the World Health Organization, is among the seven major tropical diseases, endemic in 98 countries and is considered a public health problem that causes 20 to 40 thousand deaths annually. The control of the disease is a challenge faced by the competent authorities due to the diversity of agents, vectors and reservoir, besides the appearance of parasites resistant to much of the therapeutic arsenal used. Drug treatment, mainly focused on pentavalent antimonials, causes several side effects that end up decreasing therapeutic adherence and consequently increasing parasitic resistance. Compounds containing the quinoline nucleus have a wide variety of biological effects, including antimalarial and antileishmanial activity. In this context, the synthesis, characterization and evaluation of the leishmanicidal activity of four new 4-aminoquinoline compounds: D4, D5, D6 and D7, as well as the starting compounds D1 and D3, and the symmetrical D2 bisquinoline, were used. biological. The new compounds were obtained through two different methodologies, the first two (D4 and D5) via Sonogashira reaction and the other two (D6 and D7) via nucleophilic aromatic substitution reaction (SNAR). All were characterized by 1H and 13C (NMR) nuclear magnetic resonance spectroscopy, as well as Infrared Region (IR) Absorption Spectroscopy. The yield of the obtained products were moderate, being between 40 and 70%. The seven 4-aminoquinolinic compounds were evaluated for i) their toxicity in J774.A1 macrophages ii) their in vitro activity against L. amazonensis promastigotes iii) their in vitro activity against L. chagasi promastigotes. The results showed that in the evaluation of cytotoxicity compounds D1 and D5 had the lowest toxicity (LC50 87.8 ± 4.5 and 88.6 ± 11.6) among the compounds tested, in addition to D3 that showed no toxicity up to the maximum concentration (100 μM). In the evaluation of the leishmanicidal activity, monoquinolines D4 and D5 showed no significant activity until the maximum concentration used, although the starting compound D3 showed good activity against L. chagasi (LC50 10 μM ± 1,4). The dissimetric D6 and D7 bisquinolines showed activity against the promastigote forms of L. amazonensis and L. chagasi, however, the D6 was the best activity against both species (CI50 5.7 ± 1.8, 8.2 ± 0, 4). The other compounds were not active until the maximum concentration tested. In summary, the work showed that the formation of the bisquinolines favored the increase of the leishmanicidal activity in vitro when compared to the monoquinolines, at least in front of the analyzed species and in the concentrations tested.
id UFAL_26b87505c11dd1d99e95da6f3f307774
oai_identifier_str oai:www.repositorio.ufal.br:riufal/5880
network_acronym_str UFAL
network_name_str Repositório Institucional da Universidade Federal de Alagoas (UFAL)
repository_id_str
spelling Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicosSynthesis and evaluation of the Leishmanicide activity of new 4-aminoquinolinic CompoundsLeishmanioseAminoquinolinas4,7-dicloroquinolinaLeishmaniasis4-aminoquinolines4,7-dichloroquinolineLeishmanicidal activityCNPQ::CIENCIAS DA SAUDE::FARMACIALeishmaniasis, according to the World Health Organization, is among the seven major tropical diseases, endemic in 98 countries and is considered a public health problem that causes 20 to 40 thousand deaths annually. The control of the disease is a challenge faced by the competent authorities due to the diversity of agents, vectors and reservoir, besides the appearance of parasites resistant to much of the therapeutic arsenal used. Drug treatment, mainly focused on pentavalent antimonials, causes several side effects that end up decreasing therapeutic adherence and consequently increasing parasitic resistance. Compounds containing the quinoline nucleus have a wide variety of biological effects, including antimalarial and antileishmanial activity. In this context, the synthesis, characterization and evaluation of the leishmanicidal activity of four new 4-aminoquinoline compounds: D4, D5, D6 and D7, as well as the starting compounds D1 and D3, and the symmetrical D2 bisquinoline, were used. biological. The new compounds were obtained through two different methodologies, the first two (D4 and D5) via Sonogashira reaction and the other two (D6 and D7) via nucleophilic aromatic substitution reaction (SNAR). All were characterized by 1H and 13C (NMR) nuclear magnetic resonance spectroscopy, as well as Infrared Region (IR) Absorption Spectroscopy. The yield of the obtained products were moderate, being between 40 and 70%. The seven 4-aminoquinolinic compounds were evaluated for i) their toxicity in J774.A1 macrophages ii) their in vitro activity against L. amazonensis promastigotes iii) their in vitro activity against L. chagasi promastigotes. The results showed that in the evaluation of cytotoxicity compounds D1 and D5 had the lowest toxicity (LC50 87.8 ± 4.5 and 88.6 ± 11.6) among the compounds tested, in addition to D3 that showed no toxicity up to the maximum concentration (100 μM). In the evaluation of the leishmanicidal activity, monoquinolines D4 and D5 showed no significant activity until the maximum concentration used, although the starting compound D3 showed good activity against L. chagasi (LC50 10 μM ± 1,4). The dissimetric D6 and D7 bisquinolines showed activity against the promastigote forms of L. amazonensis and L. chagasi, however, the D6 was the best activity against both species (CI50 5.7 ± 1.8, 8.2 ± 0, 4). The other compounds were not active until the maximum concentration tested. In summary, the work showed that the formation of the bisquinolines favored the increase of the leishmanicidal activity in vitro when compared to the monoquinolines, at least in front of the analyzed species and in the concentrations tested.CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorA leishmaniose, segundo a Organização Mundial da Saúde, está entre as sete principais doenças tropicais, endêmica em 98 países, sendo considerada um problema de saúde pública que causa anualmente de 20 a 40 mil mortes. O controle da doença é um desafio enfrentado pelas autoridades competentes devido à diversidade de agentes, vetores e reservatório, além do surgimento de parasitos resistentes a boa parte do arsenal terapêutico utilizado. O tratamento medicamentoso, centrado principalmente nos antimoniais pentavalente, provocam diversos efeitos colaterais que acabam diminuindo a adesão terapêutica e consequentemente aumentando a resistência parasitária. Compostos contendo o núcleo quinolínico possuem uma ampla variedade de efeitos biológicos, entre elas, atividade antimalárica e antileishmanial. Nesse contexto, realizou-se a síntese, caracterização e avaliação da atividade leishmanicida de quatro novos compostos 4-aminoquinolínicos: D4, D5, D6 e D7, além dos compostos de partida D1 e D3, e da bisquinolina simétrica D2, utilizada apenas na avaliação biológica. Os novos compostos foram obtidos através de duas metodologias diferentes, sendo os dois primeiros (D4 e D5) via reação de Sonogashira e os outros dois (D6 e D7) via reação de substituição nucleofílica aromática (SNAR). Todos foram caracterizados por espectroscopia de ressonância magnética nuclear de 1H e 13C (RMN), além da Espectroscopia de Absorção na Região de Infravermelho (IV). Os rendimentos dos produtos obtidos foram moderados, ficando entre 40 e 70%. Os sete compostos 4-aminoquinolinicos foram avaliados quanto à: i) sua toxicidade em macrófagos da linhagem J774.A1 ii) sua atividade in vitro contra promastigotas da L. amazonensis iii) sua atividade in vitro contra promastigotas da L. chagasi. Os resultados obtidos mostraram que na avaliação da citotoxicidade os compostos D1 e D5 apresentaram a menor toxicidade (CL50 87,8 ± 4,5 e 88,6 ± 11,6) dentre os compostos testados, além do D3 que não exibiu toxicidade até a máxima concentração testada (100 μM). Na avaliação da atividade leishmanicida, as monoquinolinas D4 e D5 não apresentaram atividade significante até a máxima concentração utilizada, embora o composto de partida D3 tenha demostrado boa atividade frente a L. chagasi (CL50 10 μM ± 1,4). As bisquinolinas dissimétricas D6 e D7 mostraram atividade frente as formas promastigotas das L. amazonensis e L. chagasi, entretanto o composto D6 foi o que obteve melhor atividade frente a ambas espécies (CI50 5,7 ± 1,8; 8,2 ± 0,4). Os demais compostos não foram ativos até a máxima concentração testada. Em resumo, o trabalho mostrou que a formação das bisquinolinas favoreceu o aumento da atividade leishmanicida in vitro quando comparada às monoquinolinas, pelo menos frente as espécies analisadas e nas concentrações testadas.Universidade Federal de AlagoasBrasilPrograma de Pós-Graduação em Ciências FarmacêuticasUFALMeneghetti, Mario Robertohttp://lattes.cnpq.br/6642503680426310Araújo Júnior, João Xavier dehttp://lattes.cnpq.br/5717734170464420Araújo, Morgana Vital dehttp://lattes.cnpq.br/3726617532728221Barros, Daniele Costa Souza2019-09-04T18:46:01Z2019-08-152019-09-04T18:46:01Z2019-03-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfBARROS, Daniele Costa Souza. Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos. 2019. 110 f. Dissertação (Mestrado em Ciências Farmacêuticas) – Instituto de Ciências Farmacêuticas, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Alagoas, Maceió, 2019.http://www.repositorio.ufal.br/handle/riufal/5880porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da Universidade Federal de Alagoas (UFAL)instname:Universidade Federal de Alagoas (UFAL)instacron:UFAL2019-09-04T18:46:01Zoai:www.repositorio.ufal.br:riufal/5880Repositório InstitucionalPUBhttp://www.repositorio.ufal.br/oai/requestri@sibi.ufal.bropendoar:2019-09-04T18:46:01Repositório Institucional da Universidade Federal de Alagoas (UFAL) - Universidade Federal de Alagoas (UFAL)false
dc.title.none.fl_str_mv Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
Synthesis and evaluation of the Leishmanicide activity of new 4-aminoquinolinic Compounds
title Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
spellingShingle Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
Barros, Daniele Costa Souza
Leishmaniose
Aminoquinolinas
4,7-dicloroquinolina
Leishmaniasis
4-aminoquinolines
4,7-dichloroquinoline
Leishmanicidal activity
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
title_full Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
title_fullStr Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
title_full_unstemmed Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
title_sort Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos
author Barros, Daniele Costa Souza
author_facet Barros, Daniele Costa Souza
author_role author
dc.contributor.none.fl_str_mv Meneghetti, Mario Roberto
http://lattes.cnpq.br/6642503680426310
Araújo Júnior, João Xavier de
http://lattes.cnpq.br/5717734170464420
Araújo, Morgana Vital de
http://lattes.cnpq.br/3726617532728221
dc.contributor.author.fl_str_mv Barros, Daniele Costa Souza
dc.subject.por.fl_str_mv Leishmaniose
Aminoquinolinas
4,7-dicloroquinolina
Leishmaniasis
4-aminoquinolines
4,7-dichloroquinoline
Leishmanicidal activity
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Leishmaniose
Aminoquinolinas
4,7-dicloroquinolina
Leishmaniasis
4-aminoquinolines
4,7-dichloroquinoline
Leishmanicidal activity
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Leishmaniasis, according to the World Health Organization, is among the seven major tropical diseases, endemic in 98 countries and is considered a public health problem that causes 20 to 40 thousand deaths annually. The control of the disease is a challenge faced by the competent authorities due to the diversity of agents, vectors and reservoir, besides the appearance of parasites resistant to much of the therapeutic arsenal used. Drug treatment, mainly focused on pentavalent antimonials, causes several side effects that end up decreasing therapeutic adherence and consequently increasing parasitic resistance. Compounds containing the quinoline nucleus have a wide variety of biological effects, including antimalarial and antileishmanial activity. In this context, the synthesis, characterization and evaluation of the leishmanicidal activity of four new 4-aminoquinoline compounds: D4, D5, D6 and D7, as well as the starting compounds D1 and D3, and the symmetrical D2 bisquinoline, were used. biological. The new compounds were obtained through two different methodologies, the first two (D4 and D5) via Sonogashira reaction and the other two (D6 and D7) via nucleophilic aromatic substitution reaction (SNAR). All were characterized by 1H and 13C (NMR) nuclear magnetic resonance spectroscopy, as well as Infrared Region (IR) Absorption Spectroscopy. The yield of the obtained products were moderate, being between 40 and 70%. The seven 4-aminoquinolinic compounds were evaluated for i) their toxicity in J774.A1 macrophages ii) their in vitro activity against L. amazonensis promastigotes iii) their in vitro activity against L. chagasi promastigotes. The results showed that in the evaluation of cytotoxicity compounds D1 and D5 had the lowest toxicity (LC50 87.8 ± 4.5 and 88.6 ± 11.6) among the compounds tested, in addition to D3 that showed no toxicity up to the maximum concentration (100 μM). In the evaluation of the leishmanicidal activity, monoquinolines D4 and D5 showed no significant activity until the maximum concentration used, although the starting compound D3 showed good activity against L. chagasi (LC50 10 μM ± 1,4). The dissimetric D6 and D7 bisquinolines showed activity against the promastigote forms of L. amazonensis and L. chagasi, however, the D6 was the best activity against both species (CI50 5.7 ± 1.8, 8.2 ± 0, 4). The other compounds were not active until the maximum concentration tested. In summary, the work showed that the formation of the bisquinolines favored the increase of the leishmanicidal activity in vitro when compared to the monoquinolines, at least in front of the analyzed species and in the concentrations tested.
publishDate 2019
dc.date.none.fl_str_mv 2019-09-04T18:46:01Z
2019-08-15
2019-09-04T18:46:01Z
2019-03-21
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv BARROS, Daniele Costa Souza. Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos. 2019. 110 f. Dissertação (Mestrado em Ciências Farmacêuticas) – Instituto de Ciências Farmacêuticas, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Alagoas, Maceió, 2019.
http://www.repositorio.ufal.br/handle/riufal/5880
identifier_str_mv BARROS, Daniele Costa Souza. Síntese e avaliação da atividade leishmanicida de novos compostos 4-aminoquinolínicos. 2019. 110 f. Dissertação (Mestrado em Ciências Farmacêuticas) – Instituto de Ciências Farmacêuticas, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Alagoas, Maceió, 2019.
url http://www.repositorio.ufal.br/handle/riufal/5880
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Alagoas
Brasil
Programa de Pós-Graduação em Ciências Farmacêuticas
UFAL
publisher.none.fl_str_mv Universidade Federal de Alagoas
Brasil
Programa de Pós-Graduação em Ciências Farmacêuticas
UFAL
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal de Alagoas (UFAL)
instname:Universidade Federal de Alagoas (UFAL)
instacron:UFAL
instname_str Universidade Federal de Alagoas (UFAL)
instacron_str UFAL
institution UFAL
reponame_str Repositório Institucional da Universidade Federal de Alagoas (UFAL)
collection Repositório Institucional da Universidade Federal de Alagoas (UFAL)
repository.name.fl_str_mv Repositório Institucional da Universidade Federal de Alagoas (UFAL) - Universidade Federal de Alagoas (UFAL)
repository.mail.fl_str_mv ri@sibi.ufal.br
_version_ 1748233743765602304